Previous close | 6.21 |
Open | 6.25 |
Bid | 6.75 x 600 |
Ask | 6.78 x 600 |
Day's range | 5.81 - 6.90 |
52-week range | 1.74 - 6.90 |
Volume | |
Avg. volume | 1,587,946 |
Market cap | 2.086B |
Beta (5Y monthly) | 1.35 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
Despite Revenue Growth, Company Faces GAAP Net Loss and Provides 2024 Guidance